Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report

Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report

Abstract Background Non-vitamin K antagonist oral anticoagulants, including dabigatran, are currently widely used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Recently, idarucizumab, a monoclonal antibody fragment for immediate reversal of dab...

Full description

Bibliographic Details
Main Authors: Sergio Agosti, Laura Casalino, Enrico Rocci, Gabriele Zaccone, Eugenia Rota
Format: Article
Language:English
Published: BMC 2017-08-01
Series:Journal of Medical Case Reports
Subjects:
Dabigatran
Idarucizumab
Ischemic stroke
Non-vitamin K antagonist oral anticoagulants
Thrombolysis
Online Access:http://link.springer.com/article/10.1186/s13256-017-1404-2

Internet

http://link.springer.com/article/10.1186/s13256-017-1404-2

Similar Items